openPR Logo
Press release

Oncology Biosimilars Market Prospects Outlook 2019-2027 and Top Key Players - Biocon, Celltrion , Dr. Reddy's Laboratories , Amgen , Intas Pharmaceuticals, Pfizer , Sandoz International GmbH (A Novartis Division)

05-07-2019 01:41 PM CET | Health & Medicine

Press release from: ReportsWeb

Oncology Biosimilars Market

Oncology Biosimilars Market

Biosimilars are the fastest-growing class of therapeutic products across the globe. Biosimilars are biologics that serves as interchangeable products offering additional treatment options to a branded drug counterpart, potentially reducing the cost of the prescribed biologics. The biosimilar therapies have been for chronic disease management and supportive care since a few years, however the use of these biosimilars are expected to be applied soon for treatment of various types of cancers referred to as oncology biosimilars.

The market for oncology biosimilars market is expected to witness growth due to extensive research undertaken by market players to bring biosimilars for cancer treatment in the market as well as rapid approval by regulatory authorities for commercialization of these products. However, high costs involved in the research and complexity involved in the formulation of these biologics are likely to hinder market growth.

The "Global Oncology Biosimilars Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global oncology biosimilars market with detailed market segmentation by product, cancer type, and distribution channel. The global oncology biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Get Sample copy @ http://bit.ly/2DWa1ZT

Some of the key players influencing the market are:
Biocon, Celltrion , Dr. Reddy's Laboratories , Amgen , Intas Pharmaceuticals, Pfizer , Sandoz International GmbH (A Novartis Division), Teva Pharmaceutical Industries Ltd., Mylan N.V., and BIOCAD among others.

The global oncology biosimilars market is segmented on the basis of product, cancer type, and distribution channel. On the basis of product, the global oncology biosimilars market is segmented into monoclonal antibodies, Immunomodulators, and others. On the basis of cancer type, the global oncology biosimilars market is segmented in to lung cancer, colorectal cancer, cervical cancer, breast cancer, kidney cancer, stomach cancer, brain cancer, and others. On the basis of distribution channel, the oncology biosimilars market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.

The oncology biosimilars market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oncology biosimilars market based product, cancer type, and distribution channel. It also provides market size and forecast till 2027 for overall oncology biosimilars market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Have any questions? Ask here @ http://bit.ly/2vJ54iM

North America dominated the oncology biosimilars market in 2017, owing to the rapid approval of biosimilars by US FDA. Moreover, various market players in the US and Canada have robust pipeline of biosimilars that are expected to be soon approved suggesting high growth rate of the region in the coming years. Asia Pacific on the other hand is expected witness the highest growth over the forecast period owing to the availability of immense opportunities in countries like India, China & Japan. Rising government initiatives for incorporating cost-efficient treatment options for various type of cancer in middle and low income economies of the region are expected to be the driving factors for Asian growth.

Table of Content:

1. Introduction
2. Key Takeaways
3. Oncology Biosimilars Market Landscape
4. Oncology Biosimilars Market - Key Industry Dynamics
5. Oncology Biosimilars Market - Global Analysis
6. Oncology Biosimilars Market Revenue and Forecasts to 2027 - By Product
7. Oncology Biosimilars Market Revenue and Forecasts to 2027 - By Cancer Type
8. Oncology Biosimilars Market Revenue and Forecasts to 2027 - By Distribution Channel
9. North America Oncology Biosimilars Market Revenue and Forecasts to 2027 - Country Analysis
10. Europe Oncology Biosimilars Market Revenue and Forecasts to 2027 - Country Analysis
11. Asia Pacific Oncology Biosimilars Market Revenue and Forecasts to 2027 - Country Analysis
12. Middle East and Africa (Mea) Oncology Biosimilars Market Revenue and Forecasts to 2027 - Country Analysis
13. South and Central America Oncology Biosimilars Market Revenue and Forecasts to 2027 - Country Analysis
14. Industry Landscape
15. Oncology Biosimilars Market, Key Company Profiles

Get Interesting Discount @ http://bit.ly/2JjQciE

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Biosimilars Market Prospects Outlook 2019-2027 and Top Key Players - Biocon, Celltrion , Dr. Reddy's Laboratories , Amgen , Intas Pharmaceuticals, Pfizer , Sandoz International GmbH (A Novartis Division) here

News-ID: 1729907 • Views:

More Releases from ReportsWeb

Global Security Analytics Market by 2028 covers Size, Share, Upcoming Trends Seg …
Global Security Analytics Market Analysis to 2028 is a specialized and in-depth study of the industry with a focus on the global market trend. The report aims to provide an overview of global Market with detailed market segmentation by product/application and geography. Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. Some of the
Global Fuel Management System Market Analysis of Features, Benefits, Manufacturi …
Global Fuel Management System Market Analysis to 2028 is a specialized and in-depth study of the industry with a focus on the global market trend. The report aims to provide an overview of global Market with detailed market segmentation by product/application and geography. Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period. Some of
Global Biometric Sensor Market Size 2021 - COVID19 Impact with Top Manufacturers Analysis | Industry Share, Revenue Forecast till 2030
Global Biometric Sensor Market Size 2021 - COVID19 Impact with Top Manufacturers …
The Global Biometric Sensor Market Research Report 2020-2027 Published by Premium Market Insights, a conspicuous statistical surveying firm incorporates bits of knowledge into the market. The report has been set up by experienced and proficient market experts and scientists. They have investigated the serious scene, division, geological development, and income, creation, and utilization development of the worldwide Biometric Sensor market and included the record. Players can utilize the exact market
Robotic Position Sensor Market Forecast, 2021–2030 | by Mechanism, Measurement Duration & Application
Robotic Position Sensor Market Forecast, 2021–2030 | by Mechanism, Measurement …
The Global Robotic Position Sensor Market Research Report 2020-2027 Published by Premium Market Insights, a conspicuous statistical surveying firm incorporates bits of knowledge into the market. The report has been set up by experienced and proficient market experts and scientists. They have investigated the serious scene, division, geological development, and income, creation, and utilization development of the worldwide Robotic Position Sensor market and included the record. Players can utilize the

All 5 Releases


More Releases for Biosimilars

Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biosimilars Market Size During the Forecast Period? The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth? The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million